Metabolic Homeostasis of Amino Acids and Diabetic Kidney Disease

Nutrients. 2022 Dec 30;15(1):184. doi: 10.3390/nu15010184.

Abstract

Diabetic kidney disease (DKD) occurs in 25-40% of patients with diabetes. Individuals with DKD are at a significant risk of progression to end-stage kidney disease morbidity and mortality. At present, although renal function-decline can be retarded by intensive glucose lowering and strict blood pressure control, these current treatments have shown no beneficial impact on preventing progression to kidney failure. Recently, in addition to control of blood sugar and pressure, a dietary approach has been recommended for management of DKD. Amino acids (AAs) are both biomarkers and causal factors of DKD progression. AA homeostasis contributes to renal hemodynamic response and glomerular hyperfiltration alteration in diabetic patients. This review discusses the links between progressive kidney dysfunction and the metabolic homeostasis of histidine, tryptophan, methionine, glutamine, tyrosine, and branched-chain AAs. In addition, we emphasize the regulation effects of special metabolites on DKD progression, with a focus on causality and potential mechanisms. This paper may offer an optimized protein diet strategy with concomitant management of AA homeostasis to reduce the risks of DKD in a setting of hyperglycemia.

Keywords: amino acids; diabetic kidney disease; intestinal microecology; metabolic homeostasis; metabolites.

Publication types

  • Review

MeSH terms

  • Amino Acids
  • Diabetes Mellitus, Type 2* / complications
  • Diabetic Nephropathies* / etiology
  • Disease Progression
  • Homeostasis
  • Humans
  • Kidney / metabolism

Substances

  • Amino Acids